ID   OUR-20
AC   CVCL_A417
SY   OUR20; Osaka University Renal carcinoma-20
DR   Cosmic; 849367
DR   Wikidata; Q54936815
RX   PubMed=1958632;
RX   PubMed=11146448;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Leufs*7 (c.1005dupA) (c.1005_1006insA); Zygosity=Unspecified (PubMed=11146448).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=1958632;
RA   Sugao H., Seguchi T., Nakano E., Sonoda T., Matsuda M., Goto T.,
RA   Onishi S., Kawaguchi N.;
RT   "Establishment and characterization of new cell lines from human renal
RT   cell carcinoma.";
RL   Hum. Cell 4:137-144(1991).
//
RX   PubMed=11146448; DOI=10.1002/1097-0215(200002)9999:9999<::AID-IJC1034>3.0.CO;2-S;
RA   Kondo K.-i., Yao M., Kobayashi K., Ota S., Yoshida M., Kaneko S.,
RA   Baba M., Sakai N., Kishida T., Kawakami S., Uemura H., Nagashima Y.,
RA   Nakatani Y., Hosaka M.;
RT   "PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and
RT   renal carcinoma cell lines.";
RL   Int. J. Cancer 91:219-224(2001).
//